Skip to Content


Filter by:



Second Opinion

Learn about policy issues important to medical schools and teaching hospitals, with Executive Vice President Atul Grover, M.D., Ph.D.

Washington Highlights

AAMC Signs Group Letter Regarding House Legislation on Opioids

May 13, 2016—The AAMC May 12 joined the Premier Healthcare Alliance, American College of Physicians, Medical Group Management Association, National Association of Accountable Care Organizations, and the American Academy of Family Physicians in a letter  strongly urging the House leadership to include language in the final House opioids legislative package to allow certain stakeholders access to a patient’s entire medical record, including substance use disorder-related information, to promote effective valued-based care.

Current regulations (42.C.F.R. Part 2 (Part 2)) preclude the Centers for Medicare and Medicaid Services (CMS) from disclosing drug and alcohol treatment and prevention records to providers, including accountable care organizations (ACOs) and bundled payment organizations. The groups state the regulations “require complex and multiple patient consents for the use and disclosure of patients’ substance use records that go beyond the sufficiently strong patient confidentiality protections that were subsequently put in place by the Health Insurance Portability and Accountability Act (HIPAA).”

The letter further highlights the transition to new delivery system models such as ACOs and bundled payments focused on a more holistic, patient-centered approach to health care. It states, “Critical to making these new models truly work for patients is having access to the individuals’ health records, including those related to substance use,” and “ensuring that the health care providers who are on the front-lines treating those with opioid or other substance use disorders have an unobstructed view of their patients’ medical records.”

“Accordingly, we call on Congress to ensure that the Medicare, Medicaid and SCHIP data feeds sent to providers that are participating in alternative payment models such as Medicare ACOs and bundled payment arrangements include all claims, including those where a substance use disorder is listed as a primary or secondary diagnosis.”

Contact:

Courtney Summers
Senior Legislative Analyst
Telephone: 202-862-6042
Email: csummers@aamc.org

Len Marquez
Director, Government Relations
Telephone: 202-862-6281
Email: lmarquez@aamc.org

.

envelope on a green background

Subscribe to Washington Highlights

RSS icon

Subscribe to RSS

Washington Highlights, a weekly electronic newsletter, features brief updates on the latest legislative and regulatory activities affecting medical schools and teaching hospitals.


Past Issues


For More Information

Jason Kleinman
Sr. Legislative Analyst, Govt. Relations
Telephone: 202-903-0806
Email: jkleinman@aamc.org